Evidence map›Paper›PMID 27821085›Full record

ArticleBMC infectious diseases2016

Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).

I Rivero-Calle, J Pardo-Seco, P Aldaz, D A Vargas, E Mascarós, E Redondo, J L Díaz-Maroto, M Linares-Rufo, M J Fierro-Alacio, A Gil and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2023
    Article
  10. Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns.Enfermedades infecciosas y microbiologia clinica · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. [Influenza and cardiorespiratory events: a clinical-epidemiological review with a multidisciplinary point of view].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

I Rivero-CalleTranslational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Travesía da Choupana, s/n, 15706, Santiago de Compostela, Spain.
J Pardo-SecoGenetics, Vaccines, Infections and Pediatrics Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
P AldazMember of the Infectious Diseases Prevention Group PAPPS-SEMFYC, Primary Health Care Center San Juan, Pamplona, Spain.
D A VargasVersatile Hospitalization Unit, Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería, Spain.
E MascarósHealth Department, Hospital Dr Peset, Primary Care Center Fuente de San Luís, Valencia, Spain.
E RedondoPreventive and Public Health Activities Group SEMERGEN, International Heath Center, Madrid, Spain.
J L Díaz-MarotoPrimary Care Health Center Guadalajara, Infectious Diseases Group SEMERGEN, Guadalajara, Spain.
M Linares-RufoPrimary Care and Clinical Microbiology, Infectious Diseases Group SEMERGEN, Fundación io, Spain.
M J Fierro-AlacioPrimary Care Health Center El Olivillo, Cádiz, Spain.
A GilPreventive Medicine and Public Health, Rey Juan Carlos University, Madrid, Spain.
J MolinaPrimary Care Respiratory Group, Health Care Center Francia, Fuenlabrada, Madrid, Spain.
D OcañaPrimary Care Respiratory Group, Health Care Center Algeciras, Algeciras, Spain.
Federico Martinón-TorresTranslational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Travesía da Choupana, s/n, 15706, Santiago de Compostela, Spain. federico.martinon.torres@sergas.es.ORCID 0000-0002-9023-581X
NEUMOEXPERTOS group
Complejo Hospitalario Universitario de Santiago · ESHospital de Poniente · ESMadrid Health Service · ESUniversidad Rey Juan Carlos · ESHospital Universitario Doctor Peset · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommunity-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults even in developed countries. Several lifestyle factors and comorbidities have been linked to an increased risk, although their prevalence has not been well documented in the primary care setting. The aim of this study is to assess the incidence, risk factor and comorbid conditions distribution of CAP in adults in primary care in Spain.

methodsRetrospective observational study in adults (>18 years-old) with CAP diagnosed and attended at primary care in Spain between 2009 and 2013, using the Computerized Database for Pharmacoepidemiological Studies in Primary Care (BIFAP).

resultsTwenty-eight thousand four hundred thirteen patient records were retrieved and analyzed. Mean age (standard deviation): 60.5 (20.3) years, 51.7 % males. Global incidence of CAP in adults was estimated at 4.63 per 1000 persons/year. CAP incidence increased progressively with age, ranging from a 1.98 at 18-20 years of age to 23.74 in patients over 90 years of age. According to sex, global CAP incidence was slightly higher in males (5.04) than females (4.26); CAP incidence from 18 to 65 year-olds up was comparable between males (range: 2.18-5.75) and females (range: 1.47-5.21), whereas from 65 years of age, CAP incidence was noticeable higher in males (range: 7.06-36.93) than in females (range: 5.43-19.62). Average prevalence of risk factors was 71.3 %, which increased with age, doubling the risk in males by the age of 75 (females 20 % vs males 40 %). From 55 years of age, at least one risk factor was identified in 85.7 % of cases: one risk factor (23.8 %), two risk factors (23.4 %), three or more risk factors (38.5 %). Major risk factors were: metabolic disease (27.4 %), cardiovascular disease (17.8 %) and diabetes (15.5 %).

conclusionsThe annual incidence of CAP in primary care adults in Spain is high, comparable between males and females up to 65 years of age, but clearly increasing in males from that age. CAP risk increases with age and doubles in males older than 75 years. The majority of CAP cases in patients over 55 years of age is associated to at least one risk factor. The main risk factors associated were metabolic disease, cardiovascular disease, and diabetes.

Indexed as

AdolescentAdultAgedAged, 80 and overCardiovascular DiseasesCommunity-Acquired InfectionsDeveloped CountriesFemaleHumansIncidenceLife StyleMaleMedical RecordsMetabolic DiseasesMiddle AgedPneumoniaAntibioticsCommunity-acquired pneumoniaIncidencePrimary careRisk factorsVaccine-preventable diseases

Identifiers

PMID27821085
PMCPMC5100110
OpenAlexW2553809876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.